In breast cancer cells and Nb2 cells, PRL stimulates ERK1/2 phosphorylation in the mitogen-activated protein (MAP) kinase pathway, which appears to mediate the effects of PRL on cell proliferation [39,40]. This evidence concerns the gene MAPK3 and breast carcinoma.